Long Term Retention of Protspectively Obtained Biospecimens

Background:

This protocol is designed to have samples from closing protocols transferred to this protocol
for long-term storage. The protocol is concerned with the retention of blood, plasma, serum,
CSF, aspirates, bone marrow, ascites fluid, urine, saliva, PBMCs, skin, mucosal, tumor and
healthy tissue samples from patients with cancer to support basic science and clinical
research activities of the Genitourinary Malignancies Branch (GMB) and other intramural
Laboratories and Branches at the NIH Clinical Research Center and Center for Cancer Research.

Objectives:

To allow long-term storage of biospecimens collected during prospective clinical trials in
patients with various cancer phenotypes, as needed to support the research activities of the
Genitourinary Malignancies Branch (GMB) and other Laboratories and Branches.

Eligibility:

Samples eligible for long-term retention must be from those who have signed consent for
storage and retention of biospecimens.

Design:

Acquired samples will be barcoded and associated data will be entered into an encrypted
computer software system, and securely maintained to protect patient identifiers. Samples are
retained and made available to the original Principal Investigator (PI), or other
investigators with the original PI's permission, following submission and approval of a
supplemental research protocol to the IRB or OHSRP.

- INCLUSION CRITERIA:

Patient volunteers or Legally Authorized Representative (LAR) must have signed a consent on
a previously IRB approved protocol for storing biospecimens for future research.

Age is greater than or equal to 18 years of age.

EXCLUSION CRITERIA: